Catalyst Pharma (CPRX)
NASDAQ:CPRX
Holding CPRX?
Track your performance easily

Catalyst Pharma (CPRX) Financial Statements

2,061 Followers

Catalyst Pharma Financial Overview

Catalyst Pharma's market cap is currently ―. The company's EPS TTM is $0.533; its P/E ratio is 38.29; Catalyst Pharma is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 122.71M$ 98.51M$ 110.57M$ 102.69M$ 99.48M
Gross Profit$ 107.31M$ 85.99M$ 94.76M$ 88.52M$ 87.54M
EBIT$ 55.79M$ 38.43M$ 41.69M$ -38.02M$ 48.51M
EBITDA$ 65.22M$ 47.86M$ 50.84M$ -29.45M$ 57.08M
Net Income Common Stockholders$ 40.79M$ 23.27M$ 34.84M$ -22.28M$ 37.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 375.69M$ 310.41M$ 137.64M$ 120.97M$ 178.79M
Total Assets$ 706.36M$ 646.68M$ 470.11M$ 413.21M$ 443.90M
Total Debt$ 2.99M$ 3.09M$ 3.19M$ 3.28M$ 3.38M
Net Debt$ -372.70M$ -307.32M$ -134.45M$ -117.69M$ -175.41M
Total Liabilities$ 97.70M$ 85.26M$ 82.23M$ 64.66M$ 68.60M
Stockholders Equity$ 608.65M$ 561.41M$ 387.88M$ 348.55M$ 375.29M
Cash Flow-
Free Cash Flow$ 64.13M$ 31.73M$ 55.55M$ 45.06M$ 30.75M
Operating Cash Flow$ 64.14M$ 31.93M$ 55.65M$ 45.13M$ 30.75M
Investing Cash Flow$ -10.00K$ -199.00K$ -38.32M$ -92.82M-
Financing Cash Flow$ 1.16M$ 141.05M$ -665.00K$ -10.13M$ -214.00K
Currency in USD

Catalyst Pharma Earnings and Revenue History

Catalyst Pharma Debt to Assets

Catalyst Pharma Cash Flow

Catalyst Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis